IRIS
GAGLIARDINI, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.934
NA - Nord America 1.447
AS - Asia 854
SA - Sud America 112
AF - Africa 40
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.394
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.416
RU - Federazione Russa 446
IT - Italia 365
SG - Singapore 344
GB - Regno Unito 312
IE - Irlanda 228
CN - Cina 212
DE - Germania 174
SE - Svezia 112
BR - Brasile 99
VN - Vietnam 92
FR - Francia 83
FI - Finlandia 66
HK - Hong Kong 64
UA - Ucraina 37
IN - India 30
KR - Corea 30
NL - Olanda 26
ES - Italia 22
BE - Belgio 20
CA - Canada 20
TR - Turchia 17
AT - Austria 16
ZA - Sudafrica 13
UG - Uganda 10
AR - Argentina 7
ID - Indonesia 7
MX - Messico 7
PK - Pakistan 7
PT - Portogallo 7
BD - Bangladesh 6
IQ - Iraq 6
JP - Giappone 6
ET - Etiopia 5
PL - Polonia 5
AU - Australia 4
LT - Lituania 4
MA - Marocco 4
PH - Filippine 4
AE - Emirati Arabi Uniti 3
JO - Giordania 3
MY - Malesia 3
AZ - Azerbaigian 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
EU - Europa 2
IR - Iran 2
KE - Kenya 2
PA - Panama 2
SA - Arabia Saudita 2
TW - Taiwan 2
UZ - Uzbekistan 2
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GY - Guiana 1
IL - Israele 1
IM - Isola di Man 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
QA - Qatar 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 4.394
Salva come PNG Salva come JPEG
Città #
Southend 266
Singapore 231
Dublin 216
Dallas 207
Moscow 144
Ashburn 128
Munich 123
Chandler 113
Santa Clara 102
Fairfield 96
Beijing 72
Hong Kong 63
Dong Ket 56
Ann Arbor 52
Helsinki 49
Siena 44
Woodbridge 40
New York 37
Milan 36
Princeton 33
Seattle 33
Jacksonville 32
Los Angeles 32
Seoul 30
Hefei 29
Houston 29
Menlo Park 29
Wilmington 28
Rome 23
Cambridge 21
Málaga 19
Brussels 15
Shanghai 14
Dearborn 13
Lauterbourg 13
London 13
Boardman 12
Buffalo 12
Düsseldorf 12
Hanoi 12
San Mateo 12
The Dalles 12
Turku 12
Ho Chi Minh City 11
São Paulo 11
Vienna 11
Frankfurt am Main 10
Nanjing 10
Portsmouth 9
Kampala 8
Montreal 8
Perugia 8
Redondo Beach 8
Bengaluru 7
Chennai 7
Florence 7
Nuremberg 7
Washington 7
Castel Volturno 6
Council Bluffs 6
Fremont 6
San Francisco 6
Tokyo 6
Addis Ababa 5
Atlanta 5
Chicago 5
Guangzhou 5
Spring 5
Warsaw 5
Brooklyn 4
Cagliari 4
Columbus 4
Deiva Marina 4
Denver 4
Grosseto 4
Izmir 4
Jyväskylä 4
Naples 4
San Diego 4
Toronto 4
Treviso 4
Akyurt 3
Americana 3
Amman 3
Amsterdam 3
Ankara 3
Belo Horizonte 3
Bologna 3
Boston 3
Campobasso 3
Cape Town 3
Charlotte 3
Genoa 3
Istanbul 3
Lisbon 3
Lucknow 3
Manila 3
Mexico City 3
Nanchang 3
Norwalk 3
Totale 2.859
Salva come PNG Salva come JPEG
Nome #
"EFFICACY AND SAFETY OF 2-DRUG COMBINATION ANTIRETROVIRAL THERAPY IN CLINICAL PRACTICE: RESULTS FROM A SINGLE CENTER STUDY" 529
UTILIZZO DI MILTEFOSINA IN PAZIENTE CON LEISHMANIOSI MUCOSA ED INFEZIONE DA HIV 428
Impact of the M184V resistance mutation on virological efficacy and durability of lamivudine-based dual antiretroviral regimens as maintenance therapy in individuals with suppressed HIV-1 RNA: A cohort study 252
Predicting 2-drug antiretroviral regimen efficacy by genotypic susceptibility score: results from a cohort study 252
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 246
HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART 232
Impact of resistance mutations on virological efficacy of DTG-based maintenance two-drug regimens: a cohort study 218
Predicting 2-drug antiretroviral regimen efficacy by genotypic susceptibility score: results from a cohort study 216
Use of Miltefosine in a Patient With Mucosal Leishmaniasis and HIV-coinfection: A Challenge in Long-Term Management 195
Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients – evidence from a large observational cohort 194
Impact of resistance mutations on virological efficacy of DTG-based maintenance two-drug regimens: an ARCA cohort study 186
Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: A multi-cohort study 165
Impact of resistance mutations on efficacy of dolutegravir plus rilpivirine or plus lamivudine as maintenance regimens: a cohort study 158
Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects 137
Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: A retrospective study from the clinical practice 131
Simplification to High Genetic Barrier 2-Drug Regimens in People Living With HIV Harboring 4-Class Resistance Enrolled in the PRESTIGIO Registry 122
Endocardite o non endocardite? Questo è il dilemma. 111
Efficacia viro-immunologica dei regimi antiretrovirali duplici e triplici contenenti dolutegravir: risultati di uno studio di coorte 111
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 105
Lack of HIV seroconversion in a patient treated immediately with antiretroviral therapy at acute infection and virus relapse 98
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of view 87
Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort 86
Sexually transmitted infections in people with multidrug-resistant HIV 78
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study 75
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors 71
Totale 4.483
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.802
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.802
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021267 0 0 0 0 0 29 33 41 37 36 13 78
2021/2022300 11 31 16 23 17 13 19 18 34 20 30 68
2022/2023421 26 51 65 41 25 76 15 32 33 28 15 14
2023/2024435 12 8 38 28 20 114 125 16 2 15 29 28
2024/20251.063 19 31 81 33 136 105 108 82 121 46 108 193
2025/20261.400 185 211 188 311 492 13 0 0 0 0 0 0
Totale 4.483